Yes, it has been reported. Parkinsonism is a frequent side effect of some calcium channel blockers (CCB), especially cinnarizine and flunarizine. CCB-induced parkinsonism (CCBIP) usually improves spontaneously after discontinuation of the offending drug, but many patients exhibit persistent symptoms.

See also:

Calcium channel blocker-induced parkinsonism: clinical features and

comparisons with Parkinson’s disease

Pedro J. Garcı´a-Ruiza, Feelix Javier Jimenez-Jimenezb,*, Justo Garcı´a de Ye´benesa.

But L-type calcium channel blockers of the dihydropyridine class may have potentially neuroprotective effect and protect again Parkinson's disease - "L-Type Calcium Channel blockers and Parkinson’s Disease in Denmark"

Beate Ritz, MD, PhD,1,* Shannon L. Rhodes, PhD,1 Lei Qian, PhD,2 Eva Schernhammer, MD, DrPH,3 Jorgen Olsen, MD,4 and Soren Friis, MD4

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917467/

Thank you Dear Luiza for valuable data.

Good question. As Luiza_Chwiszczuk already commented some calcium channel blocker have antidopaminergics properties and  may  induce extrapyramidal reaction including dystonia  (Micheli F et al. Flunarizine- and cinnarizine-induced extrapyramidal reactions Neurology. 1987 ;37(5):881-4). Certainly this is not frequent at all with dihydropyridine,  but there are anecdotic cases 

In any cases, some patients with mild dystonia complain of ¨stiffness¨ …so dystonia might  explain this  peculiar side effect

Thank you Dear Pedro for valuable explanation.